Diagnostyka S.A. Stock: price and insider trades · Poland
Diagnostyka S.A.: what insiders have been doing
Every trade that managers of Diagnostyka S.A. disclose to KNF is tracked on this page. The company sits in the Health Care sector. In the past year (7 November 2025 to 7 November 2026), 4 filings came from 1 insider.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
For context, the typical company on the same exchange (median of 561 companies) published 3 filings over the same period, against 4 filings here.
No insider has bought Diagnostyka S.A. shares on the open market in the past twelve months.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Source: insider filings from KNF. Past trades are no guide to future returns.
Analyst consensus: bullish or bearish?
Analysts rate Diagnostyka S.A. Buy (bullish), based on 7 analysts. Average price target: PLN 191.39.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ●Executives0KNF
- ●Executives0KNF
- ●Executives0KNF
- ●Executives0KNF
4 of 4 declarations
About Diagnostyka S.A.
Diagnostyka S.A. is a company specializing in the healthcare and pharmaceutical sector, providing medical diagnostic services. It is listed on the XWAR market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
